This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Hikma Pharmaceuticals (HIK.L) - Announced a new licensing agreement with Takeda for products in the Middle East and north Africa, expanding its licensing and distribution agreement with Takeda with the inclusion of will new products to its portfolio. Closing price 1329.00p (Reuters)
Kingfisher PLC (KGF.L) - Reported a 2% fall in quarterly sales, worse than Q1, hurt by weak French markets, a slowdown at its B&Q business in the UK and continued disruption from its restructuring plan. It also remained cautious on the outlook for H2 this year. Closing price 307.40p (Reuters)
Vectura Group PLC (VEC.L) – And Hikma Pharmaceuticals continue constructive talks with the FDA after a complete response letter issued on abbreviated new drug application for generic version of GlaxoSmithKline’s Advair Diskus. The FDA have confirmed there are no material issues regarding the substitutability of the proposed device. Closing price 114.00p (Bloomberg)
For more information on any of these individual news items, call into the trading floor
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research